Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health - Quiz - MDSpire

Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health

  • By

  • Chi-Hsien Lee

  • Thi Phuong Nam Bui

  • Camille Petitfils

  • Ching Jian

  • Giselle C Wong

  • Anthony Puel

  • Tiphaine Le Roy

  • Samuel Bellais

  • Bouthaina Ben Abdallah

  • Mélanie Nehlich

  • Thomas Leicht

  • Manyi Jia

  • Lesley Hoyles

  • Massimo Federici

  • Jose Manuel Fernández-Real

  • Remy Burcelin

  • Marc-Emmanuel Dumas

  • Nathalie M Delzenne

  • Thomas Clavel

  • Sjef Boeren

  • Antonio Dario Troise

  • Andrea Scaloni

  • Giulio G Muccioli

  • Willem M De Vos

  • Matthias Van Hul

  • Patrice D Cani

  • July 1, 2026

  • 0 min

Share

Original Source(s)

Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health

  • by Chi-Hsien Lee, Thi Phuong Nam Bui, Camille Petitfils, Ching Jian, Giselle C Wong, Anthony Puel, Tiphaine Le Roy, Samuel Bellais, Bouthaina Ben Abdallah, Mélanie Nehlich, Thomas Leicht, Manyi Jia, Lesley Hoyles, Massimo Federici, Jose Manuel Fernández-Real, Remy Burcelin, Marc-Emmanuel Dumas, Nathalie M Delzenne, Thomas Clavel, Sjef Boeren, Antonio Dario Troise, Andrea Scaloni, Giulio G Muccioli, Willem M De Vos, Matthias Van Hul, Patrice D Cani

  • July 1, 2026

Related Content

Laparoscopic Roux-en-Y Gastric Bypass with the Maestro™ System: a Novel Collaborative Robotic Platform

NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases

Publisher Correction: Machine Learning Models for Predicting Significant Liver Fibrosis in Patients with Severe Obesity and Nonalcoholic Fatty Liver Disease